期刊文献+

miRNA-21通过对血小板源性生长因子B和血管内皮生长因子的调控促进肝星状细胞活化的研究 被引量:4

miRNA-21 promotes the activation of hepatic stellate cells by regulating platelet-derived growth factor beta and vascular endothelial growth factor
原文传递
导出
摘要 目的研究miRNA-21通过对血小板源性生长因子B(PDGF-B)和血管内皮生长因子(VEGF)的调控促进肝星状细胞(HSC)活化的分子机制。方法将大鼠肝星状细胞HSC-T6分为正常组、酒精组、miRNA-21模拟物组和miRNA-21抑制剂组。正常组给予含有10%胎牛血清的DMEM培养基正常培养48 h;酒精组给予含有100 mmol·L^(-1)乙醇和10%胎牛血清的DMEM培养基培养48 h;miRNA-21模拟物组将miRNA-21模拟物用Lip3000转染试剂瞬时转染入细胞,再用含有100 mmol·L^(-1)乙醇和10%胎牛血清的DMEM培养基培养48 h;miRNA-21抑制剂组将miRNA-21抑制剂用Lip3000转染试剂瞬时转染入细胞,再用含有100 mmol·L^(-1)乙醇和10%胎牛血清的DMEM培养基培养48 h。用CCK-8实验检测细胞的增殖情况,用蛋白质印迹法检测PDGF-B和VEGF因子的表达情况。结果正常组、酒精组、miRNA-21模拟物组和miRNA-21抑制剂组的细胞增殖率分别为0.17±0.01,0.27±0.01,0.49±0.03和0.14±0.01。PDGF-B在酒精组的表达量(0.45±0.04)均显著高于正常组(0.21±0.03,P<0.05)和miRNA-21抑制剂组(0.20±0.03,P<0.01),而显著低于miRNA-21模拟物组的表达量(0.88±0.05,P<0.01)。VEGF在各组的表达变化则与PDGF-B的表达变化相同。结论miRNA-21能够通过对PDGF-B和VEGF的调控来促进HSC的增殖与活化,促进HSC成纤维化的进展。 Objective To study the molecular mechanism that miRNA-21 promotes the activation of hepatic stellate cell(HSC)through the regulation of platelet-derived growth factor beta(PDGF-B)and vascular endothelial growth factor(VEGF).Methods Passage HSC-T6 rat hepatic stellate cells were divided into normal,alcohol,miRNA-21 mimic and miRNA-21 inhibitor groups.Among them,the normal group was not treated;the miRNA-21 mimic group transiently transfected the miRNA-21 mimic into HSC;the miRNA-21 inhibitor group transiently transfected the miRNA-21 inhibitor into HSC.Then,change the cell culture medium to a medium containing 100 mmol·L^(-1) ethanol to induce the activation of HSC in the alcohol,miRNA-21 mimic and miRNA-21 inhibitor groups.Four groups were treated for 48 hours.Cell proliferation was detected by CCK-8 experiment.The expressions of PDGF-B and VEGF factors were detected by Western blot.Results The cell proliferation rates of the normal,alcohol,miRNA-21 mimic and miRNA-21 inhibitor groups were 0.17±0.01,0.27±0.01,0.49±0.03 and 0.14±0.01,respectively.The expressions of PDGF-B in the alcohol group(0.45±0.04)were significantly higher than those in normal group(0.21±0.03,P<0.05)and miRNA-21 group(0.20±0.03,P<0.01),while significantly lower than that in miRNA-21 mimic group(0.88±0.05,P<0.01).The expression change of VEGF in each group was the same as that of PDGF-B.Conclusion miRNA-21 can promote the proliferation and activation of HSC by regulating PDGF-B and VEGF,and promote the progress of HSC fibrosis.
作者 杨欢 李三强 程维刚 张兵兵 张艺博 代新华 洪晓敏 侯航 樊高芳 苏梦尧 王艺 YANG Huan;LI San-qiang;CHENG Wei-gang;ZHANG Bing-bing;ZHANG Yi-bo;DAI Xin-hua;HONG Xiao-min;HOU Hang;FAN Gao-fang;SU Meng-yao;WANG Yi(Key Laboratory of Molecular Medicine for Liver Injury and Repair,School of Basic Medicine,Henan University of Science and Technology,Luoyang 471000,Henan Province,China;Henan Engineering Research Center for Liver Disease Prevention,Luoyang 471000,Henan Province,China;Thyroid and Breast Surgery,The First Affiliated Hospital of Henan University of Science and Technology,Luoyang 471000,Henan Province,China)
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2022年第11期1223-1226,共4页 The Chinese Journal of Clinical Pharmacology
基金 国家自然科学基金资助项目(81201558) 河南省科技创新杰出青年基金资助项目(184100510006) 河南省高校科技创新团队基金资助项目(18IRTSTHN026) 中原科技创新领军人才计划基金资助项目(214200510004) 洛阳市科技发展计划基金资助项目(2101028A)。
关键词 MIRNA-21 血小板源性生长因子-B 血管内皮生长因子 肝星状细胞 miRNA-21 platelet-derived growth factor beta vascular endothelial growth factor hepatic stellate cell
  • 相关文献

参考文献3

二级参考文献34

  • 1Lee AS, Mira-Avendano I, Ryu JH, et al. The burden of idiopathic pulmonary fibrosis: An unmet public health need [ J ]. Respir Med, 2014, 108(7) : 955 -967.
  • 2Cottin V, Crestani B, Valeyre D, et al. Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines[ J]. Eur Respir Rev, 2014, 23(132) : 193 -214.
  • 3Knipe RS, Tager AM, Liao JK. The Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosis [ J]. Pharmacol Rev, 2015, 67 ( 1 ) : 103 - 117.
  • 4Thickett DR, Kendall C, Spencer LG, et al. Improving care for patients with idiopathic pulmonary fibrosis (IPF) in the UK: a round table discussion[J]. Thorax, 2014, 69(12) : 1136 -1140.
  • 5Nandadasa S, Foulcer S, Apte SS. The multiple, complex roles of versican and its proteolytic turnover by ADAMTS proteases during embryogenesis[J]. Matrix Biol, 2014, 35(1) : 34 -41.
  • 6Mancek-Keber M. Inflammation-mediating proteases: structure, function in (patho) physiology and inhibition [ J ]. Protein Pept Lett, 2014, 21(12) : 1209 -1229.
  • 7Zhou TB, Jiang ZP. Role of miR-21 and its signaling pathways in renal diseases[J]. J Recept Signal Transduct Res, 2014, 34(5) : 335 - 337.
  • 8Li P, Zhao GQ, Chen TF, et al. Serum miR-21 and miR-155 expression in idiopathic pulmonary fibrosis [ J]. J Asthma, 2013, 50(9) : 960 -964.
  • 9Liu G, Friggeri A, Yang Y, et al. miR-21 mediates fflm3genic activation ff pulmonary fibroblasts and lung fibrosis [ J]. J Exp Med, 2010, 207(8) : 1589 -1597.
  • 10Booton R, IJndsay MA. Emerging role of nfiemRNAs and long nonesding RNAs in respiratory disease[ J ]. Chest, 2014, 146 ( 1 ) : 193 -204.

共引文献149

同被引文献33

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部